HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Chuang Xu Selected Research

selitrectinib

7/2022Conformational adjustment overcomes multiple drug-resistance mutants of tropomyosin receptor kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Chuang Xu Research Topics

Disease

2Neoplasms (Cancer)
07/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
07/2022 - 10/2021
2Phosphotransferases (Kinase)IBA
07/2022 - 10/2021
2TropomyosinIBA
07/2022 - 10/2021
1selitrectinibIBA
07/2022